NUCLERA LTD

Active Cambridge

Research and experimental development on biotechnology

121 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NUCLERA LTD

Research and experimental development on biotechnology

Founded 27 Aug 2013 Active Cambridge, United Kingdom 121 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

NUCLERA NUCLEICS LTD 27 Aug 2013 — 13 Apr 2023
Accounts Submitted 22 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 11 Sept 2025 Next due 10 Sept 2026 4 months remaining
Net assets £91M £37M 2024 year on year
Total assets £105M £36M 2024 year on year
Total Liabilities £15M £782K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

One Vision Park Station Road Impington Cambridge CB24 9NP United Kingdom

Website

www.example.com

Full company profile for NUCLERA LTD (08663936), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 27 Aug 2013. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2021–2024)

Cash in Bank

£51.01M

Increased by £38.00M (+292%)

Net Assets

£90.77M

Increased by £36.99M (+69%)

Total Liabilities

£14.56M

Decreased by £782.47k (-5%)

Turnover

£1.27M

Increased by £1.18M (+1303%)

Employees

121

Decreased by 13 (-10%)

Debt Ratio

14%

Decreased by 8 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 7

Investors (21)

Investor NameInvestor SinceParticipating Rounds
Investor 16Jan 2018Series A, Series B
Investor 14Jan 2020Unknown/Other
Investor 15Jan 2020Unknown/Other, Series B

Share Capital

Share Capital

Share allotments and capital structure

29 Allotments 9,553,017 Shares £78.49m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
16 Dec 202597,520£9.752£0
16 Dec 202597,520£9.752£0
2 Dec 20251,114,106£9.08m£8.149
1 Oct 2025717,699£71.77£71.77
1 Oct 2025717,699£71.77£71.77

Officers

Officers

3 active
Status
Joseph KeeganDirectorAmericanUnited States7310 Jun 2020Active
Michael MccrearyDirectorAmericanUnited States7918 May 2021Active
Michael WassermanDirectorAmerican,canadianCanada5116 Aug 2024Active

Shareholders

Shareholders (53)

Elevage Medical Technologies Gp Llc In Its Capacity As General Partner Of Nature Aggregator Lp
20.8%
3,249,483
Danaher Ventures Llc
7.2%
1,125,064

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Michael Chun Hao Chen

Ceased 15 Nov 2018

Ceased

Gordon Ross Mcinroy

Ceased 15 Nov 2018

Ceased

Jiahao Huang

Ceased 15 Nov 2018

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Mortlock House, Station Road, Impington, Cambridge (CB24 9NP) SOUTH CAMBRIDGESHIRE
Leasehold-20 Feb 2023
Mortlock House, Station Road, Impington, Cambridge (CB24 9NP)
Leasehold
Added 20 Feb 2023
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
6 Mar 2026MiscellaneousReplacement filing of SH01 - 16/12/25 Statement of Capital gbp 1755.9574
21 Jan 2026ResolutionResolutions
15 Jan 2026CapitalAllotment of shares (GBP 1,684.1875) on 16 Dec 2025
15 Jan 2026CapitalAllotment of shares (GBP 1,674.4355) on 2 Dec 2025
15 Oct 2025CapitalAllotment of shares (GBP 1,635.4823) on 3 Oct 2025
6 Mar 2026 Miscellaneous

Replacement filing of SH01 - 16/12/25 Statement of Capital gbp 1755.9574

21 Jan 2026 Resolution

Resolutions

15 Jan 2026 Capital

Allotment of shares (GBP 1,684.1875) on 16 Dec 2025

15 Jan 2026 Capital

Allotment of shares (GBP 1,674.4355) on 2 Dec 2025

15 Oct 2025 Capital

Allotment of shares (GBP 1,635.4823) on 3 Oct 2025

Recent Activity

Latest Activity

Replacement filing of SH01 - 16/12/25 Statement of Capital gbp 1755.9574

1 months ago on 6 Mar 2026

Resolutions

3 months ago on 21 Jan 2026

Allotment of shares (GBP 1,684.1875) on 16 Dec 2025

3 months ago on 15 Jan 2026

Allotment of shares (GBP 1,674.4355) on 2 Dec 2025

3 months ago on 15 Jan 2026

Allotment of shares (GBP 1,635.4823) on 3 Oct 2025

6 months ago on 15 Oct 2025